Recurrence: all 3,523 studies
Page 2 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- Non-Interventional Study of Puzol-cel for CD19-Positive Relapsed/Refractory B-Cell Acute Lymphoblastic LeukemiaNot yet recruitingNCT07637929
- A Study of Elranatamab Outpatient Administration in Patients With Relapsed/Refractory Multiple MyelomaRecruitingNCT07637578Phase 2
- Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image GuidanceRecruitingNCT07636148
- A Study of the LVIVO-TaVec122 Product in Subjects With Relapsed/Refractory B-cell MalignanciesNot yet recruitingNCT07628582Phase 1
- A Study in Participants With Relapsed or Refractory Multiple Myeloma for IBI3003RecruitingNCT07623798Phase 3
- Dual-Target CLDN18.2/HER2 CAR-NK Cells for Advanced Esophageal AdenocarcinomaRecruitingNCT07622940Phase 1/2
- Pirtobrutinib Maintenance After CAR-T Therapy in Relapsed or Refractory B-Cell LymphomaNot yet recruitingNCT07622784Phase 2
- Comparative 3-dimensional Superimposition Analysis of Dentition in Horizontal and Vertical Grower During the Retention Phase -A Prospective Clinical Trial''RecruitingNCT07622277Not applicable
- Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent GlioblastomasNot yet recruitingNCT07620548Phase 2
- EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCCRecruitingNCT07617805Phase 1/2
- Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2RecruitingNCT07617753Phase 1/2
- Adebrelimab Combined With SHR2554 in Relapsed/Refractory PTCL and NK/T-Cell LymphomaNot yet recruitingNCT07615283Phase 1/2
- Rimegepant Plus Glofitamab and CD19 CAR-T Therapy in R/R LBCLNot yet recruitingNCT07613788Phase 2
- A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple MyelomaNot yet recruitingNCT07612787Phase 1/2
- Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk PredictionRecruitingNCT07611838
- A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLLRecruitingNCT07609823Phase 2
- A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHLRecruitingNCT07607925Phase 1/2
- Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)Enrolling by invitationNCT07607327
- A Study of Automated Axicabtagene Ciloleucel for R/R Large B-cell Lymphoma.RecruitingNCT07606937Early Phase 1
- A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant ChemotherapyRecruitingNCT07604909Phase 2
- A Clinical Trial of Olutasidenib in Patients With Acute Myeloid LeukemiaRecruitingNCT07604064Phase 2
- Lisaftoclax Plus Chidamide and Rituximab in Relapsed or Refractory Diffuse Large B-cell LymphomaNot yet recruitingNCT07601607Phase 1/2
- Effectiveness of Positive Deviance/Hearth in Treating Uncomplicated Moderate Acute Malnutrition in Children 6-59 Months in Mymensingh Division, BangladeshEnrolling by invitationNCT07591064Not applicable
- Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBTRecruitingNCT07589413
- First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.RecruitingNCT07586618Phase 1
- IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic AnemiaNot yet recruitingNCT07585071Phase 1
- Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid TumorsRecruitingNCT07584499Phase 1
- Sintilimab Combined With Anlotinib and Taxane-Based Chemotherap for Recurrent/Metastatic Nasopharyngeal CarcinomaRecruitingNCT07581821Phase 2
- A Multicenter, Randomized, Open-label, Parallel-group, Controlled, Superiority Phase III Clinical Study Comparing the Efficacy and Safety of F182112 Versus Standard of Care in Patients With Relapsed or Refractory Multiple MyelomaRecruitingNCT07579234Phase 3
- IASO207 Injection in the Treatment of Relapsed/Refractory B-cell MalignanciesRecruitingNCT07574346Early Phase 1
- Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AMLNot yet recruitingNCT07572695
- Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell TransplantationRecruitingNCT07570407
- A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A EpendymomaNot yet recruitingNCT07567469Phase 1/2
- Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT07563179Phase 2
- A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has SpreadRecruitingNCT07543055Phase 1
- ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical CancerNot yet recruitingNCT07542717Phase 1/2
- Survival Analysis in patiEnts With Bad Prognosis Epithelial Ovarian CArcinomaRecruitingNCT07540403
- Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell LymphomaNot yet recruitingNCT07535710Phase 1/2
- A Phase I Clinical Study of KSD-101 in Patients With Relapsed or Refractory EBV-associated Hematological MalignanciesNot yet recruitingNCT07532746Phase 1
- Study to Evaluate Efficacy and Safety of Gyntima® Balance in Preventing Recurrences of Bacterial VaginosisNot yet recruitingNCT07527572Phase 2/3
- Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable PatientsNot yet recruitingNCT07526298
- Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic MalignanciesRecruitingNCT07523555Phase 1/2
- Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)Not yet recruitingNCT07521670Phase 2
- CAR 70-BCMA CAR-T Cells for the Treatment of Relapsed or Refractory Plasma Cell NeoplasmsRecruitingNCT07519187Early Phase 1
- U96-CAR-T-Cells For R/R B-ALLNot yet recruitingNCT07511426Phase 1
- Eque-cel for the Treatment of Patients With Relapsed/Refractory Multiple MyelomaNot yet recruitingNCT07510100Phase 1/2
- Fecal Microbiota Transplant vs Standard Treatment for Recurrent Non-Obstructive CholangitisNot yet recruitingNCT07509346Phase 2
- Electroacupuncture for the Prevention of Recurrent Lower Urinary Tract Infection in WomenNot yet recruitingNCT07507851Not applicable
- Tislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell LymphomaRecruitingNCT07502768Phase 1/2
- Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory NeuroblastomaRecruitingNCT07502287Phase 1/2
- NexCAR19 (Talikabtagene Autoleucel) in Relapsed/Refractory B-Cell Malignancies (NexCAR19)RecruitingNCT07502118Phase 2/3
- Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck CancerRecruitingNCT07501650Phase 1
- A Single-arm, Prospective Study of a Clad-LABU Conditioning Regimen in HSCT for R/R MDS/AML in Elderly PatientsRecruitingNCT07500753Not applicable
- MIMICC Study in Patients With Colorectal CancerRecruitingNCT07494201Not applicable
- Phase I Clinical Study to Evaluate SYS6055 Injection in Participants With Relapsed/Refractory B-Cell MalignanciesNot yet recruitingNCT07493174Phase 1
- Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic LeukemiaNot yet recruitingNCT07491263Phase 1
- Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT07490275Phase 1
- Enhancing CAR-T Cell Therapy Efficacy in B-cell Lymphoma Via Chidamide and PD-1 Inhibitor Combination.RecruitingNCT07489989Phase 2
- Shoulder Dislocation: Assessment of Lesions, Trajectories and Outcomes (SALTO)Not yet recruitingNCT07486440
- Safety and Efficacy of DIT101 in Relapsed or Refractory Hematologic MalignanciesNot yet recruitingNCT07485504Phase 1
- Effect of Postbiotics on Microbiota and Systemic Immunomodulation of Pembrolizumab as First-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (RM HNSCC)RecruitingNCT07485296Phase 2
- Predicting Recurrence in HR+/HER2- Early Breast CancerNot yet recruitingNCT07484763
- Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)RecruitingNCT07480954Phase 1/2
- Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell Lung Cancer (SCLC)RecruitingNCT07480213Phase 1/2
- Early Detection of Metastatic Recurrence Among Patients With Stage II or III Triple Negative Breast Cancer Using Liquid Biopsy and ImagingNot yet recruitingNCT07478705Not applicable
- Clinical Study of SYS6055 Injection in Participants With Relapsed/Refractory Aggressive B-Cell LymphomaNot yet recruitingNCT07476066Phase 1/2
- Dynamic Individualized Risk Profiling of Patients With Relapsed/Refractory Lymphoid Malignancies and CD19-CAR T Cell Therapy (INTeRCePT 2.0)RecruitingNCT07472972
- Effectiveness of Different Surgical Techniques for Curative Treatment of Pilonidal Sinus Disease in the Pediatric PopulationNot yet recruitingNCT07470294
- Glofitamab Combined With Lenalidomide in High Risk Patients With Relapsed or Refractory Mantle Cell LymphomaRecruitingNCT07460362Phase 2
- Peritumoral and Periganglionic Infiltration of Levobupivacaine Prior to Conservative Surgery for Triple-negative Breast CancerNot yet recruitingNCT07458204Phase 2
- Study With Glofitamab in Patients With MCL and Inadequate Response or Relapse Following CAR T-cell TherapyRecruitingNCT07453095Phase 2
- The Influence of Laser Crossectomy With Different Wavelengths on Varicose Vein ProgressionRecruitingNCT07449728Not applicable
- EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and MetastasesNot yet recruitingNCT07448376
- Exploratory Clinical Study on the Safety and Efficacy of CD19X CAR-T Cell Injection in the Treatment of Relapsed/Refractory Large B-Cell LymphomaNot yet recruitingNCT07447726Phase 1/2
- Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid TumorsNot yet recruitingNCT07444918Phase 2
- A Study of APG-3288 in Relapsed/Refractory Blood CancersRecruitingNCT07424833Phase 1
- A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal CancerRecruitingNCT07424664Phase 2
- Intratumoral DNX-2401 for High Grade Pediatric Brain TumorsRecruitingNCT07424092Phase 2
- A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloid LeukemiaNot yet recruitingNCT07423104Phase 2
- Window of Opportunity in Preserving Laryngeal Function TrialRecruitingNCT07423078Phase 2
- Dutasteride in Patients With Low Grade Non-muscle Invasive Bladder CancerRecruitingNCT07420517Phase 2
- Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent GlioblastomaRecruitingNCT07416188Phase 1/2
- A Phase III Study of SYS6010 Versus Chemotherapy in HER2-Negative, EGFR-Positive Recurrent or Metastatic Breast CancerNot yet recruitingNCT07406542Phase 3
- JY509 Universal NK Cell Injection for the Treatment of Relapsed/Refractory Pediatric B-ALLNot yet recruitingNCT07406178Early Phase 1
- Cervical Cancer Oligo States (Recurrence, Metastasis) Multicentre Outcomes Study.RecruitingNCT07400809
- Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients With Relapsed B Cell LymphomasRecruitingNCT07387848Phase 2
- The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent GliomaNot yet recruitingNCT07386002Phase 2
- Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial FibrillationNot yet recruitingNCT07382024Not applicable
- Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular CarcinomaNot yet recruitingNCT07379489
- Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple MyelomaRecruitingNCT07369895Phase 1
- Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic MalignanciesRecruitingNCT07366801Phase 2/3
- A Phase II Study of Utidelone With Toripalimab in Advanced Cervical CancerNot yet recruitingNCT07363330Phase 2
- Investigation of REcurrence Mechanisms to Adjuvant osimertINib in Radically Resected EGFR-mutated NSCLC PatientsRecruitingNCT07363252
- Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor RecurrenceNot yet recruitingNCT07361666
- Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell CancerNot yet recruitingNCT07361133Phase 2
- U69-CART-Cells For R/R T-ALLRecruitingNCT07350863Phase 1
- Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCCNot yet recruitingNCT07350824Not applicable
- A Phase 2, Single Arm Multicenter, Study Testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)Not yet recruitingNCT07348393Phase 2
- Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis RiskNot yet recruitingNCT07347977Not applicable
- Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin LymphomaNot yet recruitingNCT07345741Not applicable